NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Clinical trial NCT05026632 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05026632
- Sponsor
- Nacuity Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2026-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.